S K Garg

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi request reprint New insulin analogues
    Satish K Garg
    University of Colorado, Denver, Colorado, USA
    Diabetes Technol Ther 7:813-7. 2005
  2. ncbi request reprint Use of insulin glargine in children under age 6 with type 1 diabetes
    Brenner Dixon
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA
    Pediatr Diabetes 6:150-4. 2005
  3. ncbi request reprint Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes
    Samuel L Ellis
    Barbara Davis Center for Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 9:S48-56. 2007
  4. ncbi request reprint Health impact from frequent and continuous glucose monitoring
    Satish K Garg
    Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:523-4. 2004
  5. ncbi request reprint Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabetes Res Clin Pract 66:49-56. 2004
  6. ncbi request reprint The role of continuous glucose sensors in diabetes care
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Campus Box B 140, Denver, CO 80262, USA
    Endocrinol Metab Clin North Am 33:163-73, x-xi. 2004
  7. ncbi request reprint Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:589-95. 2004
  8. ncbi request reprint Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:9-15. 2004
  9. ncbi request reprint Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes
    Satish K Garg
    Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Care 27:734-8. 2004
  10. ncbi request reprint Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 E 9th Ave B140, Denver, CO 80262, USA
    Expert Opin Pharmacother 6:643-51. 2005

Detail Information

Publications49

  1. ncbi request reprint New insulin analogues
    Satish K Garg
    University of Colorado, Denver, Colorado, USA
    Diabetes Technol Ther 7:813-7. 2005
  2. ncbi request reprint Use of insulin glargine in children under age 6 with type 1 diabetes
    Brenner Dixon
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, CO, USA
    Pediatr Diabetes 6:150-4. 2005
    ..The purpose of this study is to evaluate the use of insulin glargine (Lantus in children under age 6 with type 1 diabetes (T1D)...
  3. ncbi request reprint Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes
    Samuel L Ellis
    Barbara Davis Center for Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 9:S48-56. 2007
    ..Phase 3 studies are ongoing to further evaluate safety and efficacy of HIIP...
  4. ncbi request reprint Health impact from frequent and continuous glucose monitoring
    Satish K Garg
    Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:523-4. 2004
  5. ncbi request reprint Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabetes Res Clin Pract 66:49-56. 2004
    ..Sixty-three subjects were taking glargine in the morning, 125 were taking glargine in the evening, and 104 were splitting the glargine dose between the morning and evening...
  6. ncbi request reprint The role of continuous glucose sensors in diabetes care
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Campus Box B 140, Denver, CO 80262, USA
    Endocrinol Metab Clin North Am 33:163-73, x-xi. 2004
  7. ncbi request reprint Reduced severe hypoglycemia with insulin glargine in intensively treated adults with type 1 diabetes
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:589-95. 2004
    ..The goal of new therapies introduced for type 1 diabetes should be to decrease hypoglycemic episodes while improving glycemic control...
  8. ncbi request reprint Glycemic parameters with multiple daily injections using insulin glargine versus insulin pump
    Satish K Garg
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Technol Ther 6:9-15. 2004
    ..However, costs and episodes of diabetic ketoacidosis are significantly higher for insulin pump users...
  9. ncbi request reprint Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes
    Satish K Garg
    Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Care 27:734-8. 2004
    ..The capability of emerging glucose sensor technology to continuously monitor glucose levels may provide ways to achieve glycemic targets while reducing hypoglycemia...
  10. ncbi request reprint Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 E 9th Ave B140, Denver, CO 80262, USA
    Expert Opin Pharmacother 6:643-51. 2005
    ..In conclusion, insulin glulisine is an effective, safe and well-tolerated rapid-acting insulin analogue...
  11. ncbi request reprint Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial
    Satish Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 1775 N Ursula St, A140, Aurora, Colorado 80010, USA
    Diabetes Care 29:44-50. 2006
    ..In this study we evaluated the accuracy, safety, and clinical effectiveness of a continuous glucose-sensing device...
  12. ncbi request reprint Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor
    Satish Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, 1775 N Ursula St A140, Aurora, CO 80010, USA
    Diabetes Care 29:2644-9. 2006
    ..In this study, we evaluated the safety and efficacy of 7-day transcutaneous, real-time, continuous glucose monitoring (CGM) in subjects with insulin-requiring diabetes...
  13. ncbi request reprint Long-term efficacy of humalog in subjects with Type 1 diabetes mellitus
    S K Garg
    Barbara Davis Center for Childhood Diabetes, Department of Paediatrics, University of Colorado Health Sciences Center, Denver, USA
    Diabet Med 16:384-7. 1999
    ..To evaluate the long-term effectiveness of Humalog insulin in lowering post meal glucose excursions...
  14. ncbi request reprint Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes
    S K Garg
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA
    Diabetes Care 22:1708-14. 1999
    ..Redwood City, CA) with capillary blood glucose values that were determined 1) in a controlled outpatient clinic setting and 2) in a home setting...
  15. pmc Feasibility of 10-day use of a continuous glucose-monitoring system in adults with type 1 diabetes
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado, USA
    Diabetes Care 32:436-8. 2009
    ..The purpose of this pilot study was to evaluate the feasibility of 10-day use of a transcutaneous, real-time, continuous glucose-monitoring (CGM) system. All previous reports using different CGM systems were for 3-, 5-, or 7-day use...
  16. doi request reprint Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes
    Samita Garg
    Department of Internal Medicine, University of Colorado at Denver and Health Sciences Center, Denver, USA
    Expert Rev Med Devices 5:113-23. 2008
    ..In this article, we discuss the features and characteristics of SoloSTAR that overcome existing unmet needs...
  17. ncbi request reprint Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado, USA
    Diabetes Care 30:3023-5. 2007
  18. ncbi request reprint Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes
    S Garg
    Department of Medicine and Paediatrics, Barbara Davis Center for Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    Diabetologia 49:891-9. 2006
    ..The efficacy and safety of human insulin inhalation powder (HIIP) plus insulin glargine were compared to subcutaneously injected insulin (SC insulin) plus insulin glargine in patients with type 1 diabetes...
  19. pmc Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Aurora, Colorado 80045, USA
    Diabetes Technol Ther 10:369-75. 2008
    ..Management of type 1 diabetes could be significantly improved with the availability of computerized insulin algorithms for home use...
  20. ncbi request reprint Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes
    H P Chase
    Department of Paediatrics, Barbara Davis Center, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabet Med 19:317-21. 2002
    ..To determine if one method of short-acting insulin bolus administration is superior to other methods in managing a meal high in carbohydrates, calories and fat...
  21. doi request reprint Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial
    S L Ellis
    Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO 80045, USA
    Diabet Med 28:1176-81. 2011
    ..This study evaluates the clinical implications of sitagliptin in adult patients with Type 1 diabetes...
  22. ncbi request reprint The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes
    H P Chase
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 24:430-4. 2001
    ....
  23. ncbi request reprint Continuous subcutaneous glucose monitoring in children with type 1 diabetes
    H P Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, Denver, Colorado 80262, USA
    Pediatrics 107:222-6. 2001
    ....
  24. ncbi request reprint Progression of coronary artery calcification in type 1 diabetes: the importance of glycemic control
    Janet K Snell-Bergeon
    Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes Care 26:2923-8. 2003
    ....
  25. ncbi request reprint Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis
    Adam Kretowski
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
    Diabetes 56:863-71. 2007
    ....
  26. ncbi request reprint Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study
    Dana Dabelea
    Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Diabetes 52:2833-9. 2003
    ..In conclusion, gender differences in insulin resistance-associated fat distribution may explain why type 1 diabetes increases coronary calcification in women relatively more than in men...
  27. ncbi request reprint ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO, USA
    J Diabetes Complications 21:273-9. 2007
    ....
  28. ncbi request reprint Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population
    David M Maahs
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Denver, CO 80262, USA
    Diabetes Care 28:301-6. 2005
    ..To compare the prevalence, awareness, treatment, and control of hypertension in a population-representative sample of adults with type 1 diabetes and comparable nondiabetic control subjects...
  29. doi request reprint Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trial
    S K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, CO 80045, USA
    Diabetes Obes Metab 13:137-43. 2011
    ..colesevelam is indicated to lower low density lipoprotein cholesterol (LDL-C) in hyperlipidaemia and improve glycaemic control in adults with type 2 diabetes. This short-term pilot study evaluates its effects in type 1 diabetes...
  30. doi request reprint Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus
    Satish Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA
    Endocr Pract 16:486-505. 2010
    ..To compare rapid-acting insulin analogues with regular human insulin in terms of hemoglobin A1c, hypoglycemia, and insulin dose when used in a basal-bolus regimen in patients with type 1 diabetes mellitus...
  31. doi request reprint Self-monitoring of blood glucose
    S K Garg
    University of Colorado Health Science Center, Aurora, CO, USA
    Int J Clin Pract Suppl . 2011
    ..Although SMBG is not 'new' technology, much research needs to be completed before we fully understand this tool's full impact, particularly as CGM becomes more popular...
  32. ncbi request reprint The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes
    A Kretowski
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Mail Stop A140, P O Box 6511, Aurora, CO 80045 6511, USA
    Diabetologia 49:1946-54. 2006
    ..The aim of the present study was to evaluate the association of apolipoprotein A-IV (APOA4) polymorphisms with coronary artery calcification (CAC) progression, a marker of subclinical atherosclerosis...
  33. ncbi request reprint 24-h ambulatory blood pressure monitoring in healthy young adult Anglo, Hispanic, and African-American subjects
    H P Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Am J Hypertens 10:18-23. 1997
    ..It also shows that higher blood pressures are present among males and among subjects of African-American descent in the teenage and young adult population...
  34. ncbi request reprint Self-efficacy impacts self-care and HbA1c in young adults with Type I diabetes
    Catharine H Johnston-Brooks
    Denver Veterans Affairs Medical Center, Denver, CO 80220, USA
    Psychosom Med 64:43-51. 2002
    ....
  35. ncbi request reprint Use of continuous glucose monitoring to improve diabetes mellitus management
    Samuel L Ellis
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Aurora, Colorado, USA
    Endocrinol Metab Clin North Am 36:46-68. 2007
  36. doi request reprint Long-acting insulin analogs versus human insulins
    Satish K Garg
    Diabetes Technol Ther 10:331-2. 2008
  37. doi request reprint Role of emerging new technologies
    Satish K Garg
    Diabetes Technol Ther 10:413-4. 2008
  38. ncbi request reprint The clinical performance and ease of use of a blood glucose meter that uses a 10-test disk
    Satish K Garg
    Department of Medicine and Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Diabetes Technol Ther 6:495-502. 2004
    ..Subjects found the meter easy and intuitive to learn to use. The study subjects were able to correctly use the meter after independently reviewing the user guide...
  39. ncbi request reprint Use of the GlucoWatch biographer in children with type 1 diabetes
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado, USA
    Pediatrics 111:790-4. 2003
    ..To determine whether use of the GlucoWatch biographer improves glucose control in children and adolescents with type 1 diabetes...
  40. ncbi request reprint Continuous glucose monitoring in type 1 diabetes
    Stuart A Weinzimer
    Yale University School of Medicine, Department of Pediatrics, PO Box 208064, 333 Cedar Street, New Haven, CT 06520, USA
    Curr Diab Rep 4:95-100. 2004
    ..The current "state of the art" of this technology, including accuracy, performance in clinical trials, limitations, and recommendations for use, is discussed for the two currently approved continuous glucose monitoring devices...
  41. ncbi request reprint Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver, Colorado, USA
    J Pediatr 143:737-40. 2003
    ..The numbers of nonsevere and severe hypoglycemic events, hemoglobin A1c values, body weight, and daily insulin dose were recorded at each clinic visit...
  42. ncbi request reprint Optimized Basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with Basal insulin glargine
    Satish K Garg
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Endocr Pract 11:11-7. 2005
    ..To compare the efficacy and safety of insulin glulisine (GLU), a new rapid-acting insulin analogue, injected 0 to 15 minutes before or immediately after meals, with regular human insulin (RHI), injected 30 to 45 minutes before meals...
  43. ncbi request reprint Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes
    Satish K Garg
    Department of Medicine, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA
    Endocr Pract 9:187-93. 2003
    ..To evaluate glycemic control and maternal and fetal outcomes of patients with type 1 diabetes treated with insulin lispro before and during pregnancy...
  44. ncbi request reprint Awareness and treatment of dyslipidemia in young adults with type 1 diabetes
    R Paul Wadwa
    Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B140, Denver, CO 80262, USA
    Diabetes Care 28:1051-6. 2005
    ..In this report, we describe the prevalence of dyslipidemia and adequacy of pharmacological treatment in patients with type 1 diabetes and comparable nondiabetic subjects...
  45. ncbi request reprint Modem transmission of glucose values reduces the costs and need for clinic visits
    H Peter Chase
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver, USA
    Diabetes Care 26:1475-9. 2003
    ..To determine whether modem technology allows for effective management of type 1 diabetes when used in lieu of a clinic visit...
  46. ncbi request reprint Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study
    Timothy S Bailey
    North County Endocrine Medical Group, Escondido, California, USA
    Diabetes Technol Ther 9:203-10. 2007
    ..Real-time continuous glucose monitoring (CGM) was studied in 140 adults with diabetes over a 12-week period of home use. Hemoglobin A(1c)(HbA1c) was measured on day 1 (baseline) and at weeks 6 and 12...
  47. pmc Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine
    Heather Ulrich
    Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver and Health Sciences Center, Denver, CO 80232, USA
    Vasc Health Risk Manag 3:245-54. 2007
    ..In summary, insulin glulisine is a safe, effective, and well tolerated rapid-acting insulin analogue across all BMIs and a worthy option for prandial glucose control in type 1 or 2 DM...
  48. ncbi request reprint Optimizing insulin therapy in pregnant women with type 1 diabetes mellitus
    Peter A Gottlieb
    Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Treat Endocrinol 1:235-40. 2002
    ..No studies of insulin aspart in pregnancy have been published in full. In addition to optimization of glycemic control, frequent assessment for development and/or progression of microvascular complications is necessary during pregnancy...
  49. ncbi request reprint Inflammatory markers and diabetic retinopathy in type 1 diabetes
    Kenneth E Izuora
    Department of Pediatrics, Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Ave, Box B 140, Denver, CO, USA
    Diabetes Care 28:714-5. 2005